| Literature DB >> 31055769 |
Adaze Bijou Enogieru1, William Lloyd Haylett2,3, Hayley Christy Miller4, Francois Hendrikus van der Westhuizen4, Donavon Charles Hiss1, Okobi Eko Ekpo5.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder that affects approximately 1% of the population over the age of 65 years. While treatment options for PD are limited, reports show that plant-derived bioactive compounds such as rutin possess numerous pharmacological benefits, including antioxidant and antiapoptotic activities. This study aimed to investigate the potential role of rutin in MPP+-treated SH-SY5Y neuroblastoma cells, an established cell model of PD. Our findings reveal increased concentrations of Ca2+ and endoplasmic reticulum (ER) stress as well as impaired mitochondrial membrane potential and bioenergetic status in SH-SY5Y cells treated with MPP+ only. This is demonstrated by a significant reduction in the expression levels of BiP, significantly reduced basal respiration, maximal respiration, and spare respiratory capacity as well as a significant increase in the expression levels of CHOP; however, these effects were significantly attenuated following pretreatment with rutin. Also, rutin significantly improved basal and compensatory glycolysis as a response to an impaired oxidative phosphorylation system triggered by MPP+, characterized by deficient ATP production. In conclusion, our findings provide the first evidence on the ability of rutin to maintain Ca2+ homeostasis, inhibit ER stress, and protect the mitochondria in MPP+-treated SH-SY5Y cells.Entities:
Keywords: ER stress; Glycolysis; Oxidative phosphorylation; Parkinson’s disease; Rutin
Mesh:
Substances:
Year: 2019 PMID: 31055769 DOI: 10.1007/s12640-019-00048-4
Source DB: PubMed Journal: Neurotox Res ISSN: 1029-8428 Impact factor: 3.911